Who We Are

By evaluating the most promising medical and scientific research, InvestBio seeks to single out the best venture capital and private equity opportunities for our clients.  A classic win-win-win situation is when a biotechnology drug or treatment is a success and the patients, scientists, and the product’s investors, all come out winners.  To achieve this, InvestBio identifies, selects, structures and manages these targeted opportunities, allowing us to create a rewarding outcome for all parties involved.

InvestBio is solely dedicated to seeking out and investing in life saving and enhancing drug treatments.  Our executive and advisory network’s broad scientific and medical experience allows us to identify the most promising research available.  Accessing this knowledge base and sifting through the research enables us to do what most investors can’t.

As InvestBio typically invests alongside our clients, our communication needs are the same.  We pride ourselves on our ability to gain access to company’s management as well as providing direct access for our investors.   InvestBio manages these relationships on a day-to-day basis in an effort to maximize our partnership’s value.  For us, information is key.  Good, bad, or indifferent, we want to keep our investors informed with up-to-date information directly from our client companies.

InvestBio often seeks board representation or access to company’s management in an effort to provide the most current information available to our investors.

For InvestBio’s biotech investment products and services please contact *DPEC Partners.